ATE378321T1 - Pyrazolopyrimidine - Google Patents

Pyrazolopyrimidine

Info

Publication number
ATE378321T1
ATE378321T1 AT05753794T AT05753794T ATE378321T1 AT E378321 T1 ATE378321 T1 AT E378321T1 AT 05753794 T AT05753794 T AT 05753794T AT 05753794 T AT05753794 T AT 05753794T AT E378321 T1 ATE378321 T1 AT E378321T1
Authority
AT
Austria
Prior art keywords
cyclin
pyrazolopyrimidines
dependent kinase
treatment
control
Prior art date
Application number
AT05753794T
Other languages
English (en)
Inventor
Qingjie Ding
Nan Jiang
John Roberts
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE378321T1 publication Critical patent/ATE378321T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT05753794T 2004-06-09 2005-06-01 Pyrazolopyrimidine ATE378321T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57825304P 2004-06-09 2004-06-09

Publications (1)

Publication Number Publication Date
ATE378321T1 true ATE378321T1 (de) 2007-11-15

Family

ID=35170008

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05753794T ATE378321T1 (de) 2004-06-09 2005-06-01 Pyrazolopyrimidine

Country Status (14)

Country Link
US (1) US7405220B2 (de)
EP (1) EP1758871B1 (de)
JP (1) JP2008501744A (de)
CN (1) CN1964954B (de)
AT (1) ATE378321T1 (de)
AU (1) AU2005251892A1 (de)
BR (1) BRPI0511975A (de)
CA (1) CA2568722A1 (de)
DE (1) DE602005003362T2 (de)
ES (1) ES2296195T3 (de)
MX (1) MXPA06014161A (de)
PL (1) PL1758871T3 (de)
RU (1) RU2412186C2 (de)
WO (1) WO2005121107A1 (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005085249A1 (en) * 2004-02-27 2005-09-15 F. Hoffmann-La Roche Ag Fused derivatives of pyrazole
CN1934111A (zh) * 2004-02-27 2007-03-21 霍夫曼-拉罗奇有限公司 杂芳基稠合的吡唑并衍生物
KR101011956B1 (ko) * 2005-08-25 2011-01-31 에프. 호프만-라 로슈 아게 Ｐ３８ ｍαｐ 키나아제 저해제 및 이의 사용 방법
US7705009B2 (en) * 2005-11-22 2010-04-27 Hoffman-La Roche Inc. 4-aminopyrimidine-5-thione derivatives
WO2007125952A1 (ja) 2006-04-28 2007-11-08 Shionogi & Co., Ltd. Ｎｐｙ ｙ５受容体拮抗作用を有するアミン誘導体
US8314234B2 (en) 2006-09-25 2012-11-20 Janssen Pharmaceutica N.V. Bicyclic pyrimidine kinase inhibitors
MX2010001636A (es) * 2007-08-14 2010-03-15 Hoffmann La Roche Derivados de pirazolo[3,4-d]-pirimidina como agentes antiproliferativos.
SA08290668B1 (ar) 2007-10-25 2012-02-12 شيونوجي آند كو.، ليمتد مشتقات أمين لها نشاط مضاد لمستقبل npy y5 واستخداماتها
KR100963644B1 (ko) 2007-11-23 2010-06-15 한국과학기술연구원 피라졸로피리미딘온 유도체 및 그의 제조방법
US8220787B2 (en) * 2008-09-19 2012-07-17 Panasonic Corporation Part mounting device
WO2010118367A2 (en) * 2009-04-10 2010-10-14 Progenics Pharmaceuticals, Inc. Antiviral pyrimidines
US8227618B2 (en) 2009-04-23 2012-07-24 Shionogi & Co., Ltd. Amine-derivatives having NPY Y5 receptor antagonistic activity and the uses thereof
US8362023B2 (en) 2011-01-19 2013-01-29 Hoffmann-La Roche Inc. Pyrazolo pyrimidines
JP2013142065A (ja) 2012-01-10 2013-07-22 Sumitomo Chemical Co Ltd 植物病害防除組成物およびその用途
CN102690270B (zh) * 2012-05-28 2014-02-05 苏州科捷生物医药有限公司 嘧啶类化合物及其用途
CN103058934A (zh) * 2013-01-07 2013-04-24 盛世泰科生物医药技术(苏州)有限公司 一种5-乙酰基-2,4-二氯嘧啶的合成方法
TWI629275B (zh) 2013-03-13 2018-07-11 賽諾菲公司 Ｎ－（４－（氮雜吲唑－６－基）－苯基）－磺醯胺及其作為醫藥之用途
DK3149008T3 (en) * 2014-05-28 2019-04-01 Shanghai Fochon Pharmaceutical Co Ltd Specific protein kinase inhibitors
GB201501115D0 (en) 2015-01-23 2015-03-11 Univ Dundee Compounds
TWI726861B (zh) 2015-01-23 2021-05-11 英商葛蘭素史克智慧財產發展有限公司 吡唑并-嘧啶化合物、其鹽及其用途
DE102016110830B4 (de) 2015-06-14 2022-01-13 Zema - Zentrum Für Mechatronik Und Automatisierungstechnik Gemeinnützige Gmbh Vorrichtung zur Befestigung einer Adaptionsplatte an einer Radnabe eines Fahrzeugs und Verfahren zum Betrieb einer Adaptionsplatte an einer Radnabe eines Fahrzeugs
US12583852B2 (en) 2018-05-02 2026-03-24 Jw Pharmaceutical Corporation Heterocycle derivative
US11066404B2 (en) 2018-10-11 2021-07-20 Incyte Corporation Dihydropyrido[2,3-d]pyrimidinone compounds as CDK2 inhibitors
US11384083B2 (en) 2019-02-15 2022-07-12 Incyte Corporation Substituted spiro[cyclopropane-1,5′-pyrrolo[2,3-d]pyrimidin]-6′(7′h)-ones as CDK2 inhibitors
TW202100520A (zh) 2019-03-05 2021-01-01 美商英塞特公司 作為cdk2 抑制劑之吡唑基嘧啶基胺化合物
WO2020205560A1 (en) 2019-03-29 2020-10-08 Incyte Corporation Sulfonylamide compounds as cdk2 inhibitors
US11447494B2 (en) 2019-05-01 2022-09-20 Incyte Corporation Tricyclic amine compounds as CDK2 inhibitors
WO2020223469A1 (en) 2019-05-01 2020-11-05 Incyte Corporation N-(1-(methylsulfonyl)piperidin-4-yl)-4,5-di hydro-1h-imidazo[4,5-h]quinazolin-8-amine derivatives and related compounds as cyclin-dependent kinase 2 (cdk2) inhibitors for treating cancer
CA3150681A1 (en) 2019-08-14 2021-02-18 Incyte Corporation Imidazolyl pyrimidinylamine compounds as cdk2 inhibitors
US11851426B2 (en) * 2019-10-11 2023-12-26 Incyte Corporation Bicyclic amines as CDK2 inhibitors
WO2021141041A1 (ja) 2020-01-07 2021-07-15 大日本住友製薬株式会社 タウオパチーの治療剤
KR20240020735A (ko) 2021-05-07 2024-02-15 카이메라 쎄라퓨틱스 인코포레이티드 Cdk2 분해제 및 그 용도
US11981671B2 (en) 2021-06-21 2024-05-14 Incyte Corporation Bicyclic pyrazolyl amines as CDK2 inhibitors
US11932648B2 (en) * 2021-06-28 2024-03-19 Blueprint Medicines Corporation CDK2 inhibitors
EP4147700A1 (de) 2021-09-08 2023-03-15 LQT Therapeutics Inc. N-(4-(azaindazol-6-yl)-phenyl)-sulfonamide zur verwendung bei der behandlung von sichelzellenkrankheit
US11976073B2 (en) 2021-12-10 2024-05-07 Incyte Corporation Bicyclic amines as CDK2 inhibitors
US12084453B2 (en) 2021-12-10 2024-09-10 Incyte Corporation Bicyclic amines as CDK12 inhibitors
WO2024238570A1 (en) * 2023-05-15 2024-11-21 Aleksia Therapeutics, Inc. Cdk2 inhibitor pyrazolopyrimidine compounds
WO2025024726A1 (en) * 2023-07-26 2025-01-30 Kinnate Biopharma Inc. Inhibitors of cyclin-dependent kinase

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9012592D0 (en) 1990-06-06 1990-07-25 Smithkline Beecham Intercredit Compounds
US5654307A (en) * 1994-01-25 1997-08-05 Warner-Lambert Company Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
PL342447A1 (en) 1997-10-27 2001-06-04 Agouron Pharma Substituted 4-amino thiazol-2-yl compounds as inhibitors of cyclin-dependent kinases
AU747705C (en) * 1997-12-13 2004-09-23 Bristol-Myers Squibb Company Use of pyrazolo (3,4-b) pyridine as cyclin dependent kinase inhibitors
WO1999043691A1 (en) * 1998-02-25 1999-09-02 Emory University 2'-fluoronucleosides
ATE342892T1 (de) 1998-08-29 2006-11-15 Astrazeneca Ab Pyrimidine verbindungen
GB9828511D0 (en) 1998-12-24 1999-02-17 Zeneca Ltd Chemical compounds
US7169778B2 (en) 1999-09-15 2007-01-30 Warner-Lambert Company Pteridinones as kinase inhibitors
EP1235815A1 (de) 1999-11-22 2002-09-04 Warner-Lambert Company Chinazoline und ihre verwendung als cyclin-dependent kinase enzym- inhibitoren
GB0004886D0 (en) 2000-03-01 2000-04-19 Astrazeneca Uk Ltd Chemical compounds
GB0004887D0 (en) 2000-03-01 2000-04-19 Astrazeneca Uk Ltd Chemical compounds
GB0004888D0 (en) 2000-03-01 2000-04-19 Astrazeneca Uk Ltd Chemical compounds
MXPA02010222A (es) 2000-04-18 2003-05-23 Agouron Pharma Pirazoles para inhibir proteina cinasa.
US6756374B2 (en) 2001-01-22 2004-06-29 Hoffmann-La Roche Inc. Diaminothiazoles having antiproliferative activity
WO2002090360A1 (en) 2001-05-10 2002-11-14 Smithkline Beecham Corporation Compounds useful as kinase inhibitors for the treatment of hyperproliferative diseases
WO2003029209A2 (en) * 2001-10-02 2003-04-10 Smithkline Beecham Corporation Chemical compounds
US6818663B2 (en) 2002-05-17 2004-11-16 Hoffmann-La Roches Diaminothiazoles
EP1545515A1 (de) * 2002-08-12 2005-06-29 Sugen, Inc. 3-pyrrolyl-pyridopyrazole und 3-pyrrolyl-indazole als neue kinase-hemmer
KR100468352B1 (ko) * 2002-09-24 2005-01-27 한국과학기술연구원 신규 피라졸로피리미딘계 유도체, 그의 제조방법 및 이를 유효성분으로 하는 약학적 조성물
US7157455B2 (en) 2003-02-10 2007-01-02 Hoffmann-La Roche Inc. 4-Aminopyrimidine-5-one derivatives
US20070179161A1 (en) 2003-03-31 2007-08-02 Vernalis (Cambridge) Limited. Pyrazolopyrimidine compounds and their use in medicine
CN1934111A (zh) * 2004-02-27 2007-03-21 霍夫曼-拉罗奇有限公司 杂芳基稠合的吡唑并衍生物

Also Published As

Publication number Publication date
US20050277655A1 (en) 2005-12-15
CA2568722A1 (en) 2005-12-22
JP2008501744A (ja) 2008-01-24
RU2007100134A (ru) 2008-07-20
RU2412186C2 (ru) 2011-02-20
DE602005003362D1 (en) 2007-12-27
ES2296195T3 (es) 2008-04-16
DE602005003362T2 (de) 2008-10-16
EP1758871B1 (de) 2007-11-14
US7405220B2 (en) 2008-07-29
WO2005121107A1 (en) 2005-12-22
EP1758871A1 (de) 2007-03-07
PL1758871T3 (pl) 2008-04-30
CN1964954A (zh) 2007-05-16
AU2005251892A1 (en) 2005-12-22
MXPA06014161A (es) 2007-01-29
BRPI0511975A (pt) 2008-01-22
CN1964954B (zh) 2010-07-21

Similar Documents

Publication Publication Date Title
ATE378321T1 (de) Pyrazolopyrimidine
NO20071794L (no) Disubstituerte pyrazolobenzodiazepiner nyttige som inhibitorer for CDK2 og angiogenese, og for behandling av bryst, tarm, lunge og prostata cancer
IL191832A (en) Pyridiazinone compounds and their use in the preparation of drugs for the treatment of tumors
ATE470668T1 (de) Pyrazolopyrimidine als inhibitoren von cyclinabhängiger kinase zur behandlung von krebs
BRPI0409366A (pt) compostos de pirimido
CY1112400T1 (el) Παραγωγα πυραζολοπυριμιδινης ως αναστολεις της εξαρτωμενης απο κυκλινη κινασης
BRPI0616987A2 (pt) pirazolopirimidinas como inibidores de cinase dependente de ciclina
BR0315912A (pt) Compostos pirimìdicos com atividade antiproliferativa (ii)
CL2008001364A1 (es) Uso de compuestos derivados de imidazol(1,2-b) piridazina y pirazolo(1,5-a) pirimidina inhibidores de tirosina quinasa pi-para tratar tumor benigno o maligno, entre otros; compuestos dereivados de imidazol(1,2-b)piridazina y pirazolo(1,5-a)pirimidina; composiciones farmaceuticas; y metodo de preparacion de compuestos.
BRPI0314001B8 (pt) pirazolopirimidinas como inibidores de cinase dependente de ciclina e composição farmacêutica compreendendo as mesmas
NO20074964L (no) Pyrimidinderivater for behandling av hyperproliferative forstyrrelser
MX2009005011A (es) Imidazopirazinas como inhibidores de proteina quinasa.
TR200103016T2 (tr) CDK2 önleyicileri olarak pirazolobenzodiazepinler
MX2010005950A (es) 2-fluoropirazolo[1,5-a]pirimidinas como inhibidores de proteina quinasa.
MX2010005300A (es) 4-pirazolil-n-arilpirimidin-2-aminas y 4-pirazolil-n-heteroarilpir imidin-2-aminas como inhibidores de cinasas janus.
TNSN08020A1 (en) 1,4-dihydropyridine-fused heterocycles, process for preparing the same, use and compositions containing them
NO20075849L (no) Fremgangsmater og preparater til behandling eller forebygging av kreft
CY1110666T1 (el) Πυραζολοπυριμιδινες καταλληλες για θεραπεια καρκινικων νοσων
DE602006016455D1 (de) Neue 4-cyano-, 4-amino-, und 4-aminomethylderivative von pyrazoloä1,5-aüpyridinen, pyrazoloä1,5-cüpyrimidinen und 2h-indazolverbindungen und 5-cyano-, 5-amino- und 5-aminomethylderivative von imidazoä1,2-aüpyridinen, und imidazoä1,5-aüpyrazinverbindungen als inhibitoren der cyclinabhänggen kinase
MX2024013266A (es) Compuestos de 6-(pirimidin-4-il)quinolina sustituidos como inhibidores de la cinasa dependiente de ciclina
ATE502025T1 (de) Arylcarboxamide und ihre verwendung als antitumormittel
EA200501233A1 (ru) 4-аминопиримидин-5-он
Dugar et al. Synthesis and evaluation of pyrrolotriazine based molecules as PI3 kinase inhibitors
ATE435224T1 (de) Neue piperidinsubstituierte diaminothiazole
WO2009047216A3 (en) Use of indolocarbazole imides as protein kinase inhibitors for the treatment of hematologic and solid tumors

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1758871

Country of ref document: EP

REN Ceased due to non-payment of the annual fee